Among all NSCLC patients with BRAF alterations of any of the three functional classes (n = 139), TP53 (75/139, 54%), CSMD3 (25/53, 47%) and TTN (24/53, 45%) represented the most frequently co-altered genes (Figure 3). This evidence concerns the gene CSMD3 and non-small cell lung carcinoma.